Copertina

Novel Benzimidazole‐Urea Phenylalanine Hybrids as Dual‐Acting Antimicrobial and Anticancer Agents: In Silico and Biological Evaluation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Tuğçe Deniz Karaca, İrfan Çapan, Yusuf Sert, Hüseyin Balcı, Arzu Aysan, İrfan Koca
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells
di: İrfan Çapan, et al.
Pubblicazione: (2025)

Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents
di: Ecem Kaya‐Sezginer, et al.
Pubblicazione: (2024)

Coumarin‐Augmented Thiazole Hybrids as Dual Anticancer and Antibacterial Agents
di: Islam K. Matar, et al.
Pubblicazione: (2026)

Benzimidazole–Oxadiazole Hybrids—Development in Medicinal Chemistry: An Overview
di: Raveendra Madhukar Bhat, et al.
Pubblicazione: (2024)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
di: Ayşen Işık, et al.
Pubblicazione: (2024)

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents
di: Ayoub Boualli, et al.
Pubblicazione: (2026)

Novel Synthesized Benzophenone Thiazole Hybrids Exhibited Ex Vivo and In Silico Anti‐Inflammatory Activity
di: Luiz Paulo Melchior de Oliveira Leão, et al.
Pubblicazione: (2024)

Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery
di: Alaa Tabaza, et al.
Pubblicazione: (2025)

Natural Pangenotypic Hepatitis C Virus Preventives‐ a Hope With Terfenadine
di: Maitri Singh, et al.
Pubblicazione: (2025)

Elucidation of the Microwave‐Assisted Synthesis and Characterization of Heteronuclear Complexes of Bisbenzimidazole Derivatives and Their Biological Activities by In Vitro and In Silico Assays
di: Esra Kaplan, et al.
Pubblicazione: (2024)

Discovery of Novel Oxadiazole‐Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies
di: Venkatraman Hegde, et al.
Pubblicazione: (2025)

Development of Quinoline‐Isoxazole Hybrids With Selective Cytotoxicity and EGFR Kinase Binding: In Vitro and In Silico Approaches
di: Yasemin Zeynep Şahin, et al.
Pubblicazione: (2025)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
di: Vijaykumar D. Nimbarte, et al.
Pubblicazione: (2025)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
di: Ozge Kuyrukcu Ozturk, et al.
Pubblicazione: (2026)

Anticancer mechanisms of β‐carbolines
di: Shivam Mishra, et al.
Pubblicazione: (2024)

Novel Donepezil–Chalcone Hybrids as Potential Multifunctional Anti‐Alzheimer’s Disease Agents: Design, Synthesis, Computational Simulation, and In Vitro/In Vivo Biological Evaluation
di: Zhiqi Lin, et al.
Pubblicazione: (2026)

Design and Development of Novel Hybrids Based on Pyrrolo[2,1‐f][1,2,4]Triazine and 1‐(Methylpiperidin‐4‐yl) Aniline–Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition
di: Balaji Dashrath Sathe, et al.
Pubblicazione: (2024)

Tyramine Derivatives as Versatile Pharmacophores With Potent Biological Properties: Sex Hormone–Binding Globulin Inhibition, Colon Cancer Antimigration, and Antimicrobial Activity
di: Jovana S. Marjanović, et al.
Pubblicazione: (2024)

Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
di: Ivana Kuzminac, et al.
Pubblicazione: (2026)

Fused and Substituted Piperazines as Anticancer Agents: A Review
di: Saumya Singh, et al.
Pubblicazione: (2025)

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin
di: Ruihan Zhao, et al.
Pubblicazione: (2024)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
di: Gözde Sayar, et al.
Pubblicazione: (2026)

Pyrazoline–Imidazopyridine Hybrids as Beclin‐1 Mimetics Driving Dual Apoptotic and Autophagy in Breast Cancer
di: Rashmi Shivakumar, et al.
Pubblicazione: (2026)

New Benzothiazole‐Thiadiazole‐Based Ketones as Potential Antiviral and Anticancer Agents: Synthesis, DFT, and Molecular Docking Studies
di: Khadra B. Alomari, et al.
Pubblicazione: (2025)

Exploring Thiazole‐Based Heterocycles: Synthesis, Bioactivity, and Molecular Docking for Antimicrobial Applications
di: Hana M. Abumelha, et al.
Pubblicazione: (2025)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
di: Shreetama Bandyopadhayaya, et al.
Pubblicazione: (2025)

Coumarin Analogues as Promising Anti‐Obesity Agents: In Silico Design, Synthesis, and In Vitro Pancreatic Lipase Inhibitory Activity
di: Nisha Yadav, et al.
Pubblicazione: (2025)

1,2,3‐Triazole Tethered Spiro[Indoline‐Oxirane] Derivatives Induce Anticancer Effects in Human Hepatoma Cells
di: Shashikala Mariswamy Rajesh, et al.
Pubblicazione: (2025)

In Vitro Cytotoxicity and Mechanistic Investigation of Quinazolin‐4(1H)‐One Linked Coumarin as a Potent Anticancer Agent
di: Dinesh Singla, et al.
Pubblicazione: (2024)

Synthesis and Molecular Modeling Studies of New Thiadiazole‐Thiophene Compounds as Potent Antimicrobial Agents
di: Nuha M. Halawani, et al.
Pubblicazione: (2025)

Anti‐Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells
di: Esraa A. Aidy, et al.
Pubblicazione: (2026)

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology
di: Rameshwar S. Cheke, et al.
Pubblicazione: (2025)

Antioxidant and Amylase, Glucosidase, and Tyrosinase Enzymes Inhibitory Potential of Genistein and 11‐α‐Hydroxyerysotrine Supported by In Silico and Network Pharmacology Approaches
di: Nouran M. Fahmy, et al.
Pubblicazione: (2025)

A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury
di: Ayse Arzu Sakul, et al.
Pubblicazione: (2024)

Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity
di: Hsu‐Feng Liu, et al.
Pubblicazione: (2024)

Design and Synthesis of Holu‐7, a Quinazolinone Derivative With an Active Stereo Geometry and Polar 2,4‐Dihydroxyphenyl Group, as a Selective Anticancer Agent
di: Kuo‐Chu Lai, et al.
Pubblicazione: (2025)

In Silico and In Vitro Identification of New Eugenol Derivatives as Inhibitors of the Spike SARS ‐ CoV ‐2 Protein Interaction With the ACE2 Host Receptor
di: Timoteo Delgado‐Maldonado, et al.
Pubblicazione: (2025)

Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
di: Ankit Kumar Singh, et al.
Pubblicazione: (2025)

In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research
di: Behnaz Yazdani, et al.
Pubblicazione: (2025)

Design, Synthesis and Biological Evaluation of Aminoalkylated Paeonol Chalcone Derivatives
di: Jia‐chen Xu, et al.
Pubblicazione: (2026)